By Dalmeet Singh Chawla2022-08-09T12:55:00
Source: © Independent Photo Agency Srl/Alamy Stock Photo
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
There is limited uptake of Covid-19 treatments targeted at immunocompromised people and those who aren’t responsive to Covid-19 vaccines, largely for reasons that remain unclear. Meanwhile, demand for antivirals appears to be slowing, even as manufacturing capacity ramps up.
Site powered by Webvision Cloud